Search Results 1341-1350 of 13315 for monoclonal antibody

1. A Phase 1 Trial Of MK-4280 As Monotherapy And In Combination With Pembrolizumab With Or Without Chemotherapy Or Lenvatinib (E7080/MK 7902) In Subjects With Advanced Solid Tumors - Mayo Clinic

   Subjects enrolled in the PD-1-treatment-failure HNSCC cohort must be refractory to an FDA approved anti-PD-1/PD-L1 monoclonal antibody ... antibodies), or ...

2. Hematology - Clinical trials

   The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

3. A Multicenter Assessment Of ALD403 In Chronic Migraine - Mayo Clinic

   Receipt of any monoclonal antibody treatment within 6 months of screening (within or outside a clinical trial); Previously dosed with ALD403 or any ...

4. Therapeutic Plasma Exchange Patients Cell Surface Proteins Plasmas - Mayo Clinic

   Proteins expressed on the tumor surface are the focus of many targeted therapies, including antibody-based treatments, antibody-drug conjugates (ADCs), T ...

5. A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments For Adult Patients With Multiple Myeloma That Is Resistant To Current Standard Of Care Treatments - Mayo Clinic

   antibody containing regimen. In addition, all ... or POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, ... antibodies is permitted, ...

6. Publications - Pingchuan Zhang, M.D., Ph.D. - Mayo Clinic

   Differing Sensitivity of Antibodies Against IgG1 ... Titan SM, Herrmann S, Leung N, Zhang P, Ansell S. Intracapillary Monoclonal IgM Deposition Concomitant With ...

7. A Study Of INCMGA00012 In Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Known hypersensitivity to another monoclonal antibody that cannot be controlled with standard measures (e.g., antihistamines and corticosteroids). Inability ...

8. A Study To Investigate The Efficacy And Safety Of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib In Adults With Relapsed/Refractory Mantle Cell Lymphoma - Mayo Clinic

   Received 1 to 5 prior lines of systemic therapy including an anti-CD20 monoclonal antibody (mAb)-based immunotherapy or chemoimmunotherapy and requiring ...

9. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

10. Mayo Clinic Q&A - Dr. Gregory Poland - COVID-19 Update Audio...

    It significantly negated the value of some of our monoclonal antibodies. So ... So, the theory had been that these allergic reactions are mediated by an antibody ...